Tag - MRT5005

Translate Bio (NASDAQ:TBIO) reported interim results from its Phase 1/2 clinical trial of MRT5005 in patients with cystic fibrosis (CF). MRT5005 is inhaled to deliver the gene that encodes functional CF transmembrane...